This study demonstrates that benzo[g]chrysene-11,12-dihydrodiol (B[g]C-11,12-dihydrodiol) derived from the fjord-region parent hydrocarbon B[g]C is oxidized by rat AKR1C9 with a k cat / K m 100 times greater than that observed with the commonly studied bay-region benzo -11,12dihydrodiol were purified by chiral RP-HPLC. The 11S,12S-stereoisomer was oxidized at the same rate as the racemate. The 11R,12R-stereoisomer did not act as an inhibitor to AKR1C9, indicating that the (-)-R,R-stereoisomer was excluded from the active site. To understand the basis of stereochemical preference, we screened alanine-scanning mutants of active site residues of AKR1C9. These studies revealed that in comparison to the wild type, F129A, W227A, and Y310A enabled the oxidation of both the B[g]C-11S,12S-dihydrodiol and the B[g]C-11R,12R-dihydrodiol. Molecular modeling revealed that unlike B[a]P-7,8-dihydrodiol and B[c]Ph-3,4-dihydrodiol, B[g]C-11,12-dihydrodiol enantiomers are significantly bent out of plane. As a consequence, the (-)-R,R-stereoisomer was prevented from binding to the active site because of unfavorable interactions with F129, W227, or Y310. Additionally, LC/MS validated that the product of the reaction of B[g]C-11,12-dihydrodiol oxidation catalyzed by AKR1C9 was B[g] C-11,12-dione, which was trapped in vitro with the nucleophile 2-mercaptoethanol. The similarity between rates of trans-dihydrodiol oxidation by the rat and human liver specific AKRs (AKR1C9 and AKR1C4) implicate these enzymes in hepatocarcinogenesis in rats observed with the fjordregion PAH.